{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fbtki-therapy-for-cll-eha-2023-umaYgoIo","width":444,"version":"1.0","type":"rich","title":"New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/48bbf652-59fd-4b91-84db-917809aab36f/cliniciansxchange-onc-pos722-btki.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/dcd61eaf-0216-4b5c-a62e-156b8c038eae\" height=\"200\" width=\"100%\" title=\"New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Gain insight into expert faculty perspectives as they discuss recent key studies from EHA 2023 on BTK inhibition in chronic lymphocytic leukemia and the potential implications for clinical practice."}